Latest Controlled substance Stories
HAGERSTOWN, Md., May 20, 2013 /PRNewswire/ -- DocuTrac, Inc. a leading developer of software for the behavioral health industry announced today that they have partnered with DrFirst to revamp the electronic prescribing functionality incorporated in their QuicDoc® EMR Professional and Enterprise Edition Software. The DrFirst integration provides a secure, powerful, and easy to use e-prescribing system. The new integration allows providers to electronically prescribe controlled...
DrFirst Controlled Substances E-prescriptions Increase 428% in 2012. DrFirst announced today that e-prescribing of controlled substances demonstrated significant growth during 2012. Rockville, MD (PRWEB) March 04, 2013 DrFirst announced today that e-prescribing of controlled substances demonstrated significant growth during 2012. A key factor in this uptake is the increase in pharmacies nationwide that are able to accept e-prescriptions for controlled substances. From February to...
DrFirst Chief Strategy and Privacy Officer, Thomas E. Sullivan, M.D., testified this month before an Office of the National Coordinator for Health Information Technology (ONC) hearing on identity proofing solutions for electronic prescribing of controlled substances. The topic of the hearing was “Sharing Trusted Identities in Cyberspace.” Dr. Sullivan indicated the second rule of medicine should be: “Secundo, tardus ne me” meaning “Second, don’t slow me down.” Rockville, MD...
The US Drug Enforcement Administration (DEA) is inspecting 6 Walgreens pharmacies and its Florida distribution center in response to a jump in purchases of oxycodone, a highly addictive pain killer. According to Reuters, the DEA has issued inspection warrants to Walgreen’s distribution center as well as stores in Hudson, Port Richey, Oviedo, Fort Meyers, and two stores in Fort Pierce, Florida. In accordance with the US Controlled Substance Act, warrants may be issued for “valid public...
DUBLIN, Ohio, Feb. 29, 2012 /PRNewswire/ -- Earlier today the federal district court denied our motion for a preliminary injunction against the DEA's immediate suspension of our license to ship controlled substances from our Lakeland, Fla., distribution center. We disagree with this decision and have noticed our appeal of this decision to the U.S. Court of Appeals for the D.C. Circuit. Our contingency plans will be immediately activated, and we will make every effort to meet...
DUBLIN, Ohio, Feb. 3, 2012 /PRNewswire/ -- Cardinal Health, one of the nation's largest health care distributors, today said it will vigorously contest the Drug Enforcement Administration's (DEA) immediate suspension of its license to distribute controlled medicines from the company's Lakeland, Fla., distribution center and will ask a federal court to block the DEA's efforts. In documents to be filed with the U.S. District Court for the District of Columbia, Cardinal Health asserts...
RANCHO CORDOVA, Calif., Jan. 25, 2012 /PRNewswire/ -- AMPAC Fine Chemicals LLC (AFC), a wholly owned subsidiary of American Pacific Corporation (Nasdaq: APFC), announced today that is has been granted Registration as a Manufacturer of Controlled Substances from the U.S. Drug Enforcement Agency (DEA). AFC has been involved in the development of Schedule II Controlled Substances since 2008 under a Researcher's License from the DEA. Recent facilities upgrades have expanded AFC's...
The Drug Enforcement Administration is expected to approve electronic prescribing vendors to allow the transmission of Schedule II Controlled Substance Orders in the very near future. This much anticipated and desired move by the DEA will dramatically improve efficiency for all prescribers, especially hospice clinicians and nurses. Delta Care Rx is the first and only Hospice Pharmacy Benefit Manager in the country to provide proprietary and certified e-Prescribing at no charge to all...
The Institute for Health Technology Transformation (iHT2) announced today that G. Cameron Deemer, President, DrFirst will serve as Conference Chair for the upcoming Electronic Prescribing of Controlled Substances (EPCS) Leadership Symposium taking place April 17-18, 2012 in Washington DC. New York, NY (PRWEB) December 29, 2011 The Institute for Health Technology Transformation (iHT2) announced today that G. Cameron Deemer, President, DrFirst will serve as Conference Chair for the upcoming...
DrFirst announces that Greenway Medical Technologies and ChartLogic are the first EHR solution providers in the country whose users are sending controlled substance prescriptions electronically. Both firms participated in a pilot implementation of EPCS Goldâ„¢, DrFirst's industry-wide, controlled substance e-prescribing solution. This service allows qualified physicians to send Schedule II-V drugs electronically to eligible pharmacies. Rockville, Md. (PRWEB) October 31, 2011...
